A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'.
Chang
Yoosoo
Y
Choi
Nam-Kyong
NK
Hahn
Seokyung
S
Park
Byung-Joo
BJ
D003327:Coronary Disease / Q000139:chemically induced*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008687:Metformin / Q000009:adverse effects*; D013453:Sulfonylurea Compounds / Q000009:adverse effects*; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D008687:Metformin